Turinabol (Chlorodehydromethyltestosterone) 10 mg
10 mg · 100 tablets · Turinabol (CDMT) is a well-characterized oral anabolic reference compound used in studies of AR-mediated anabolic signaling, steroid metabolism, long-term metabolite detection, and toxicity of 17-α-alkylated AAS.
€ 39.00
Description
Turinabol (Chlorodehydromethyltestosterone) 10 mg
Brand: Swiss Remedies
Category: Oral AAS Research Compound
Content: 100 tablets | 10 mg per tablet (1,000 mg total)
Price: €39
Manufactured in: Switzerland
🧪 Product Overview
Turinabol (CDMT) 10 mg is a synthetic anabolic-androgenic steroid designed for oral administration.
Chemically classified as 4-chlorodehydromethyltestosterone, it is derived from older testosterone-based structures
but modified through chlorination and 17-α-alkylation to improve stability and oral bioavailability.
Originally developed in the 1960s by Jenapharm (East Germany), Turinabol has become a key research compound in
androgen receptor (AR) pathway studies, anabolic signaling experiments, steroid metabolism profiling, and detection-method development.
✅ Key Research Highlights
AR-mediated anabolic activity:
Turinabol activates the androgen receptor in target tissues, stimulating protein synthesis, nitrogen retention,
and anabolic gene transcription.
Oral bioavailability via 17-α-alkylation:
Its chemical modifications allow it to resist first-pass metabolism and remain active after ingestion—ideal for
laboratory studies requiring consistent oral dosing.
Metabolic pathway research:
Liver metabolism produces long-term detectable metabolites, making Turinabol important in forensic, anti-doping, and
metabolic studies.
Comparative AAS investigations:
Often used as a benchmark compound to study differences between testosterone derivatives and chlorinated anabolic steroids.
🧬 Suggested Laboratory Applications
- Androgen receptor signaling assays
- Anabolic pathway & protein synthesis studies
- Steroid metabolism and biotransformation profiling
- Toxicology and hepatotoxicity modeling of 17-α-alkylated steroids
- Development of long-term metabolite detection methods
📊 Technical Specifications
| Field | Detail |
|---|---|
| Active Per Tablet | 10 mg Chlorodehydromethyltestosterone (CDMT) |
| Total Active Per Pack | 1,000 mg (100 × 10 mg) |
| Classification | Synthetic anabolic–androgenic steroid (AAS) |
| Chemical Formula | C20H27ClO2 |
| Primary Research Uses | AR activation studies, anabolic signaling, metabolism profiling, detection research, toxicology |
| Route of Administration | Oral tablets |
| Metabolism Notes | Hepatic metabolism; long-term metabolites detectable in urine for extended periods |
| Known Risk Domains | Hepatotoxicity, endocrine suppression, lipid profile changes, cardiovascular strain, androgenic side effects |
| Regulatory Status | Controlled/banned substance in many jurisdictions; prohibited in sports (WADA) |
❄️ PubChem-Supported Research Insights
- Strong AR-binding affinity produces measurable anabolic transcriptional effects
- Chemical modifications enhance oral bioavailability and metabolic stability
- Long-term metabolites assist detection in anti-doping research
- Useful model for analyzing liver enzyme elevation and hepatotoxic pathways
- Supports detailed metabolic profiling using CYP enzyme pathways
⚠️ Documented Research Side Effects
- Potential hepatotoxicity due to 17-α-alkylation
- Hormonal suppression affecting endocrine balance
- Changes in lipid profile (↓ HDL / ↑ LDL)
- Possible cardiovascular strain in long-term models
- Androgenic effects: hair loss, acne, shifts in sebaceous activity
🧯 Handling & Compliance
For Research Use Only — not for human or veterinary consumption.
Store in a dry, cool environment; protect from light and moisture.
Turinabol is classified as a controlled/banned substance; ensure full compliance with institutional and
jurisdictional regulations before acquisition or use.
Proper documentation, secure storage, and ethical oversight are required for all research applications.
There are no reviews yet.
